In an interview with Pharmacy Business, Malcolm Harrison explains how issues with medicine shortages are having a detrimental impact on patient care...
Uniphar’s 2024 profits were predominantly driven by organic growth, with Pharma and Medtech divisions delivering organic growth of 17.6% and 9.1% respectively